Chlamydia trachomatis antigens
AssigneeChiron Corporation
InventorGiulio Ratti
Life of this patent
Estimating the term…
Abstract
The present invention relates to antigenic proteins from Chlamydia trachomatis. A method for inducing an immune response with an immunogenic Chlamydia protein is provided in which an effective amount of an immunogenic Chlamydia protein is administered to a subject. In one example, the immunogenic Chlamydia protein has a molecular weight of about 15.8 kDa and a pI of about 4.8. In another example, the immunogenic Chlamydia protein has an N-terminal amino acid sequence of TTESLETLVE (SEQ ID NO: 2). In another example, the immunogenic Chlamydia protein is Chlamydia ribosomal protein L7/L12 or a serovar homologue of Chlamydia ribosomal protein L7/L12.
Claims6
A method of eliciting a Chlamydia specific immune response in a patient, the method comprises the step of administering to the patient an effective amount of an immunogenic protein, wherein the immunogenic protein is Chlamydia ribosomal protein L7/L12 or a serovar homologue of Chlamydia ribosomal protein L7/L12.
Dependencies are inferred from the claim text.